Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 167 | Life Science Clusters | trade journal | 0.100 Q4 | 0 | 0 | 71 | 0 | 0 | 65 | 0.00 | 0.00 |  |
| 166 | Next Generation Pharmaceutical | trade journal | 0.100 Q4 | 1 | 31 | 190 | 0 | 0 | 132 | 0.00 | 0.00 | |
| 165 | Pharmacy in Practice | journal | 0.100 Q4 | 6 | 0 | 82 | 0 | 1 | 71 | 0.00 | 0.00 | |
| 164 | Pharmacy News | journal | 0.100 Q4 | 1 | 123 | 544 | 8 | 0 | 215 | 0.00 | 0.07 | |
| 163 | Drugs in Context | journal | 0.101 Q4 | 36 | 0 | 20 | 0 | 0 | 18 | 0.00 | 0.00 | |
| 162 | EPC - European Pharmaceutical Contractor | journal | 0.101 Q4 | 3 | 65 | 223 | 269 | 3 | 218 | 0.01 | 4.14 | |
| 161 | PharmacoVigilance Review | journal | 0.101 Q4 | 2 | 23 | 23 | 53 | 0 | 18 | 0.00 | 2.30 | |
| 160 | Quality Assurance Journal | journal | 0.101 Q4 | 11 | 13 | 32 | 163 | 5 | 29 | 0.16 | 12.54 | |
| 159 | Sp2 | trade journal | 0.101 Q4 | 2 | 51 | 138 | 28 | 1 | 124 | 0.01 | 0.55 | |
| 158 | European Pharmaceutical Review | trade journal | 0.104 Q4 | 9 | 30 | 72 | 542 | 5 | 64 | 0.07 | 18.07 | |
| 157 | Paediatric and Perinatal Drug Therapy | journal | 0.104 Q4 | 20 | 0 | 9 | 0 | 1 | 8 | 0.00 | 0.00 | |
| 156 | International Journal of Neuroprotection and Neuroregeneration | journal | 0.105 Q4 | 5 | 0 | 11 | 0 | 2 | 9 | 0.00 | 0.00 | |
| 155 | Journal of Applied Therapeutic Research | journal | 0.107 Q4 | 8 | 12 | 30 | 238 | 3 | 30 | 0.06 | 19.83 | |
| 154 | Manufacturing Chemist | trade journal | 0.107 Q4 | 6 | 103 | 277 | 216 | 4 | 256 | 0.01 | 2.10 | |
| 153 | Pharmaceutical Manufacturing and Packing Sourcer | trade journal | 0.108 Q4 | 3 | 77 | 138 | 96 | 4 | 137 | 0.03 | 1.25 | |
| 152 | EBR - European Biopharmaceutical Review | journal | 0.110 Q4 | 6 | 63 | 192 | 479 | 6 | 192 | 0.04 | 7.60 | |
| 151 | Journal of Clinical Research | journal | 0.111 Q4 | 12 | 0 | 5 | 0 | 1 | 5 | 0.00 | 0.00 | |
| 150 | Innovations in Pharmaceutical Technology | trade journal | 0.115 Q4 | 9 | 0 | 189 | 0 | 16 | 181 | 0.07 | 0.00 | |
| 149 | Food Additives and Contaminants | journal | 0.121 Q4 | 121 | 174 | 386 | 6383 | 891 | 383 | 2.03 | 36.68 | |
| 148 | European Journal of Parenteral and Pharmaceutical Sciences | journal | 0.127 Q4 | 7 | 15 | 19 | 170 | 3 | 17 | 0.16 | 11.33 | |
| 147 | Regulatory Rapporteur | trade journal | 0.129 Q3 | 7 | 59 | 76 | 375 | 5 | 55 | 0.07 | 6.36 | |
| 146 | RSC Drug Discovery Series | book series | 0.130 Q4 | 13 | 0 | 28 | 0 | 2 | 11 | 0.07 | 0.00 | |
| 145 | Future HIV Therapy | journal | 0.134 Q4 | 8 | 0 | 57 | 0 | 32 | 46 | 0.00 | 0.00 | |
| 144 | Pharmaceutical Medicine | journal | 0.135 Q4 | 25 | 20 | 112 | 783 | 38 | 70 | 0.31 | 39.15 | |
| 143 | ONdrugDelivery | trade journal | 0.141 Q3 | 7 | 46 | 40 | 219 | 10 | 38 | 0.25 | 4.76 | |
| 142 | EPMA Journal | journal | 0.152 Q4 | 52 | 50 | 57 | 2820 | 48 | 52 | 0.84 | 56.40 | |
| 141 | Journal of Pharmaceutical Policy and Practice | journal | 0.153 Q3 | 32 | 18 | 15 | 436 | 9 | 10 | 0.60 | 24.22 | |
| 140 | Journal of Pharmaceutical Health Services Research | journal | 0.154 Q3 | 19 | 35 | 29 | 895 | 6 | 25 | 0.21 | 25.57 | |
| 139 | Issues in Toxicology | book series | 0.160 Q4 | 18 | 14 | 79 | 1436 | 39 | 74 | 0.44 | 102.57 | |
| 138 | Drug Discovery World | journal | 0.172 Q4 | 14 | 38 | 136 | 609 | 34 | 122 | 0.22 | 16.03 | |
| 137 | Journal of Generic Medicines (discontinued) | journal | 0.174 Q3 | 16 | 31 | 122 | 314 | 55 | 109 | 0.35 | 10.13 | |
| 136 | Journal of Venomous Animals and Toxins Including Tropical Diseases | journal | 0.182 Q4 | 41 | 66 | 204 | 2259 | 104 | 181 | 0.49 | 34.23 | |
| 135 | Therapeutic Delivery | journal | 0.206 Q3 | 63 | 143 | 70 | 8885 | 53 | 69 | 0.76 | 62.13 | |
| 134 | Pharmaceutical Journal | journal | 0.207 Q3 | 28 | 655 | 3007 | 461 | 63 | 855 | 0.02 | 0.70 | |
| 133 | International Journal of Computational Biology and Drug Design | journal | 0.214 Q4 | 16 | 27 | 80 | 588 | 35 | 78 | 0.48 | 21.78 | |
| 132 | Chemical Speciation and Bioavailability | journal | 0.259 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 131 | Journal of Negative Results in BioMedicine | journal | 0.269 Q2 | 25 | 16 | 34 | 376 | 34 | 33 | 0.77 | 23.50 | |
| 130 | DARU, Journal of Pharmaceutical Sciences | journal | 0.293 Q3 | 58 | 57 | 159 | 1338 | 167 | 158 | 0.86 | 23.47 | |
| 129 | Expert Review of Clinical Pharmacology | journal | 0.297 Q2 | 60 | 69 | 197 | 5043 | 143 | 167 | 0.77 | 73.09 | |
| 128 | IDrugs : the investigational drugs journal | journal | 0.298 Q3 | 39 | 0 | 502 | 0 | 362 | 502 | 0.82 | 0.00 | |
| 127 | Cutaneous and Ocular Toxicology | journal | 0.312 Q3 | 37 | 70 | 117 | 1462 | 127 | 114 | 1.11 | 20.89 | |
| 126 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.325 Q3 | 54 | 119 | 339 | 3002 | 271 | 336 | 0.78 | 25.23 | |
| 125 | Personalized Medicine | journal | 0.337 Q3 | 36 | 79 | 240 | 2697 | 252 | 185 | 1.19 | 34.14 | |
| 124 | Drug Discovery Today: Disease Models | journal | 0.364 Q3 | 33 | 24 | 79 | 1114 | 74 | 68 | 0.63 | 46.42 | |
| 123 | Pharmaceutical Biology | journal | 0.364 Q2 | 88 | 178 | 537 | 6266 | 648 | 531 | 1.10 | 35.20 | |
| 122 | Drug Discovery Today: Therapeutic Strategies | journal | 0.375 Q3 | 31 | 23 | 71 | 651 | 63 | 60 | 0.68 | 28.30 | |
| 121 | Toxicology Mechanisms and Methods | journal | 0.381 Q3 | 55 | 80 | 248 | 4028 | 298 | 242 | 1.23 | 50.35 | |
| 120 | International Journal of Pharmacy Practice | journal | 0.383 Q2 | 44 | 62 | 293 | 1558 | 159 | 270 | 0.70 | 25.13 | |
| 119 | Food Additives and Contaminants: Part B Surveillance | journal | 0.395 Q3 | 41 | 45 | 86 | 1305 | 83 | 85 | 0.80 | 29.00 | |
| 118 | Journal of Asian Natural Products Research | journal | 0.396 Q2 | 51 | 170 | 533 | 2915 | 563 | 532 | 1.09 | 17.15 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data